Success Metrics

Active Trials
2(33%)

Phase Distribution

Ph phase_3
1
17%
Ph phase_4
1
17%
Ph not_applicable
1
17%
Ph phase_2
3
50%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(6)

Detailed Status

Not yet recruiting4
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 23 (50.0%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A1 (16.7%)

Trials by Status

recruiting233%
not_yet_recruiting467%

Recent Activity

2 active trials
Showing 5 of 6
not_yet_recruitingphase_2

Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy

NCT07565415
recruitingnot_applicable

Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer

NCT07408505
not_yet_recruitingphase_3

Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma

NCT07356037
recruitingphase_4

A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia

NCT07243379
not_yet_recruitingphase_2

Nanocrystalline Megestrol Acetate for the Treatment of Anorexia-Cachexia Syndrome in Extensive-Stage Small Cell Lung Cancer: A Prospective, Open-Label, Single-Arm Phase II Clinical Study

NCT06909383
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07565415Phase 2

Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy

Not Yet Recruiting
NCT07408505Not Applicable

Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer

Recruiting
NCT07356037Phase 3

Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma

Not Yet Recruiting
NCT07243379Phase 4

A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia

Recruiting
NCT06909383Phase 2

Nanocrystalline Megestrol Acetate for the Treatment of Anorexia-Cachexia Syndrome in Extensive-Stage Small Cell Lung Cancer: A Prospective, Open-Label, Single-Arm Phase II Clinical Study

Not Yet Recruiting
NCT06793228Phase 2

Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

Not Yet Recruiting

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6